Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Patient Protection and Affordable Care Act | 14 | 2024 | 1209 | 3.560 |
Why?
|
Medicare Part D | 12 | 2024 | 328 | 2.810 |
Why?
|
Cost Sharing | 11 | 2023 | 407 | 1.960 |
Why?
|
Medicaid | 11 | 2024 | 2736 | 1.800 |
Why?
|
Medicare | 14 | 2023 | 6566 | 1.430 |
Why?
|
Insurance Coverage | 14 | 2023 | 1901 | 1.370 |
Why?
|
Health Services Accessibility | 9 | 2022 | 5138 | 1.010 |
Why?
|
Prescription Drugs | 3 | 2024 | 595 | 1.000 |
Why?
|
Insurance, Health | 12 | 2023 | 2494 | 0.940 |
Why?
|
California | 13 | 2023 | 1402 | 0.930 |
Why?
|
Fitness Centers | 1 | 2022 | 12 | 0.850 |
Why?
|
Community Health Centers | 4 | 2021 | 428 | 0.850 |
Why?
|
Medically Uninsured | 5 | 2022 | 853 | 0.840 |
Why?
|
Financing, Personal | 6 | 2020 | 308 | 0.830 |
Why?
|
Patient Acceptance of Health Care | 6 | 2021 | 3023 | 0.790 |
Why?
|
Mental Health Services | 4 | 2022 | 1643 | 0.790 |
Why?
|
Deductibles and Coinsurance | 4 | 2020 | 316 | 0.780 |
Why?
|
Health Expenditures | 5 | 2018 | 2348 | 0.770 |
Why?
|
United States | 52 | 2024 | 69867 | 0.750 |
Why?
|
Taxes | 2 | 2022 | 221 | 0.750 |
Why?
|
Insurance Selection Bias | 2 | 2018 | 67 | 0.720 |
Why?
|
Nurse Practitioners | 1 | 2022 | 270 | 0.670 |
Why?
|
Fees and Charges | 1 | 2019 | 195 | 0.630 |
Why?
|
Drugs, Generic | 2 | 2016 | 422 | 0.610 |
Why?
|
National Health Programs | 1 | 2020 | 445 | 0.590 |
Why?
|
Bipolar Disorder | 5 | 2022 | 5027 | 0.580 |
Why?
|
Polypharmacy | 1 | 2019 | 294 | 0.570 |
Why?
|
Insurance Benefits | 3 | 2020 | 183 | 0.570 |
Why?
|
Antipsychotic Agents | 4 | 2024 | 3058 | 0.560 |
Why?
|
Gender Identity | 1 | 2022 | 688 | 0.550 |
Why?
|
Anti-Asthmatic Agents | 5 | 2017 | 536 | 0.530 |
Why?
|
Health Facilities | 1 | 2020 | 573 | 0.520 |
Why?
|
Vaccines | 1 | 2024 | 822 | 0.510 |
Why?
|
Physicians, Primary Care | 1 | 2021 | 591 | 0.490 |
Why?
|
Medication Adherence | 4 | 2019 | 2062 | 0.470 |
Why?
|
Patient Compliance | 3 | 2018 | 2684 | 0.470 |
Why?
|
Electronic Mail | 1 | 2015 | 213 | 0.470 |
Why?
|
Poverty | 5 | 2022 | 2660 | 0.470 |
Why?
|
Asthma | 9 | 2017 | 6011 | 0.470 |
Why?
|
Risperidone | 1 | 2016 | 383 | 0.450 |
Why?
|
Income | 5 | 2020 | 1913 | 0.440 |
Why?
|
Psychiatry | 2 | 2022 | 1695 | 0.430 |
Why?
|
Influenza, Human | 1 | 2024 | 1480 | 0.430 |
Why?
|
Mental Health | 3 | 2023 | 3019 | 0.430 |
Why?
|
Leukotriene Antagonists | 4 | 2016 | 127 | 0.400 |
Why?
|
Models, Economic | 1 | 2015 | 713 | 0.400 |
Why?
|
Drug Costs | 5 | 2013 | 1105 | 0.380 |
Why?
|
Adrenal Cortex Hormones | 5 | 2016 | 1854 | 0.380 |
Why?
|
Fees, Pharmaceutical | 1 | 2009 | 64 | 0.360 |
Why?
|
Massachusetts | 7 | 2023 | 8663 | 0.340 |
Why?
|
Medically Underserved Area | 2 | 2022 | 253 | 0.340 |
Why?
|
Humans | 78 | 2024 | 744220 | 0.330 |
Why?
|
Child Health Services | 1 | 2014 | 667 | 0.320 |
Why?
|
Primary Health Care | 4 | 2021 | 4556 | 0.310 |
Why?
|
Anxiety Disorders | 1 | 2019 | 2691 | 0.310 |
Why?
|
Male | 50 | 2024 | 350027 | 0.290 |
Why?
|
Schizophrenia | 3 | 2022 | 6882 | 0.290 |
Why?
|
Office Visits | 4 | 2017 | 598 | 0.290 |
Why?
|
Tobacco Smoke Pollution | 2 | 2023 | 815 | 0.280 |
Why?
|
Substance-Related Disorders | 1 | 2023 | 4259 | 0.280 |
Why?
|
Female | 51 | 2024 | 380197 | 0.280 |
Why?
|
Mental Disorders | 2 | 2023 | 6601 | 0.270 |
Why?
|
Minority Groups | 2 | 2024 | 1223 | 0.270 |
Why?
|
Comparative Effectiveness Research | 1 | 2011 | 681 | 0.260 |
Why?
|
Aged | 28 | 2024 | 163253 | 0.260 |
Why?
|
Smoking Cessation | 3 | 2022 | 2071 | 0.260 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3256 | 0.260 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1411 | 0.260 |
Why?
|
Adrenergic beta-Agonists | 3 | 2016 | 346 | 0.250 |
Why?
|
Group Homes | 1 | 2023 | 34 | 0.240 |
Why?
|
Cohort Studies | 11 | 2024 | 40559 | 0.240 |
Why?
|
Reimbursement Mechanisms | 1 | 2009 | 670 | 0.230 |
Why?
|
Ambulatory Care Facilities | 2 | 2020 | 933 | 0.230 |
Why?
|
Depressive Disorder, Major | 1 | 2020 | 4645 | 0.220 |
Why?
|
Quality Indicators, Health Care | 2 | 2010 | 1831 | 0.220 |
Why?
|
Quality Assurance, Health Care | 2 | 2010 | 2211 | 0.210 |
Why?
|
Adult | 29 | 2024 | 214035 | 0.210 |
Why?
|
Criminals | 1 | 2023 | 62 | 0.210 |
Why?
|
Atherosclerosis | 1 | 2018 | 3444 | 0.200 |
Why?
|
Lithium | 2 | 2022 | 601 | 0.200 |
Why?
|
Tobacco Use Cessation | 1 | 2022 | 95 | 0.200 |
Why?
|
Food Supply | 2 | 2024 | 524 | 0.190 |
Why?
|
Housing | 3 | 2023 | 664 | 0.190 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 7908 | 0.180 |
Why?
|
Health Benefit Plans, Employee | 3 | 2012 | 332 | 0.180 |
Why?
|
Insurance, Medigap | 2 | 2009 | 19 | 0.170 |
Why?
|
Immunization | 1 | 2024 | 1256 | 0.170 |
Why?
|
Eligibility Determination | 1 | 2022 | 403 | 0.160 |
Why?
|
Prediabetic State | 1 | 2024 | 499 | 0.160 |
Why?
|
Middle Aged | 21 | 2023 | 213367 | 0.160 |
Why?
|
Cross-Sectional Studies | 11 | 2024 | 25043 | 0.160 |
Why?
|
Psychotic Disorders | 2 | 2024 | 3046 | 0.160 |
Why?
|
Risk Adjustment | 3 | 2011 | 594 | 0.160 |
Why?
|
Conversion Disorder | 1 | 2021 | 205 | 0.150 |
Why?
|
Clinical Competence | 2 | 2010 | 4687 | 0.150 |
Why?
|
Chlorofluorocarbons | 1 | 2016 | 12 | 0.150 |
Why?
|
Diabetes Mellitus | 3 | 2010 | 5755 | 0.140 |
Why?
|
Tobacco Use Disorder | 1 | 2022 | 688 | 0.140 |
Why?
|
Costs and Cost Analysis | 3 | 2022 | 1682 | 0.140 |
Why?
|
Young Adult | 9 | 2022 | 56436 | 0.140 |
Why?
|
Nursing Homes | 1 | 2023 | 1036 | 0.140 |
Why?
|
State Health Plans | 1 | 2018 | 216 | 0.140 |
Why?
|
Nebulizers and Vaporizers | 1 | 2016 | 139 | 0.140 |
Why?
|
Fee-for-Service Plans | 1 | 2021 | 694 | 0.140 |
Why?
|
Albuterol | 1 | 2016 | 208 | 0.130 |
Why?
|
Adolescent | 13 | 2024 | 85759 | 0.130 |
Why?
|
Socioeconomic Factors | 5 | 2018 | 7784 | 0.130 |
Why?
|
Physicians, Family | 1 | 2017 | 345 | 0.130 |
Why?
|
Hypertension | 3 | 2022 | 8480 | 0.130 |
Why?
|
Vulnerable Populations | 1 | 2020 | 686 | 0.130 |
Why?
|
Logistic Models | 7 | 2024 | 13409 | 0.130 |
Why?
|
Insurance, Pharmaceutical Services | 2 | 2009 | 336 | 0.130 |
Why?
|
Emergency Service, Hospital | 5 | 2021 | 7659 | 0.130 |
Why?
|
Professional Practice | 1 | 2016 | 326 | 0.120 |
Why?
|
Administration, Inhalation | 3 | 2015 | 1104 | 0.120 |
Why?
|
Parents | 3 | 2017 | 3407 | 0.110 |
Why?
|
Managed Care Programs | 2 | 2009 | 950 | 0.110 |
Why?
|
Emergency Services, Psychiatric | 1 | 2013 | 68 | 0.110 |
Why?
|
Drug Labeling | 1 | 2015 | 232 | 0.110 |
Why?
|
Pandemics | 2 | 2023 | 8387 | 0.110 |
Why?
|
Interviews as Topic | 4 | 2013 | 2539 | 0.110 |
Why?
|
Medical Savings Accounts | 1 | 2012 | 32 | 0.110 |
Why?
|
Data Collection | 1 | 2022 | 3340 | 0.110 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2012 | 3923 | 0.110 |
Why?
|
Telephone | 1 | 2015 | 617 | 0.110 |
Why?
|
Sexual Behavior | 1 | 2022 | 2056 | 0.100 |
Why?
|
American Recovery and Reinvestment Act | 1 | 2012 | 71 | 0.100 |
Why?
|
Anticonvulsants | 1 | 2022 | 1917 | 0.100 |
Why?
|
Antidepressive Agents | 1 | 2024 | 2839 | 0.100 |
Why?
|
Drug Prescriptions | 2 | 2015 | 1637 | 0.100 |
Why?
|
Vaccination | 1 | 2024 | 3278 | 0.100 |
Why?
|
Competitive Medical Plans | 1 | 2011 | 24 | 0.100 |
Why?
|
Child | 11 | 2023 | 77679 | 0.100 |
Why?
|
Public Housing | 2 | 2023 | 145 | 0.100 |
Why?
|
Blood Pressure | 1 | 2007 | 8551 | 0.100 |
Why?
|
Health Services Research | 1 | 2019 | 1836 | 0.100 |
Why?
|
Suicide, Attempted | 2 | 2020 | 1221 | 0.100 |
Why?
|
Hyperlipidemias | 2 | 2013 | 788 | 0.100 |
Why?
|
Medicare Part C | 1 | 2016 | 296 | 0.100 |
Why?
|
Health Planning | 1 | 2012 | 238 | 0.100 |
Why?
|
Drug Utilization | 2 | 2008 | 1183 | 0.100 |
Why?
|
Child, Preschool | 9 | 2021 | 40992 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1623 | 0.090 |
Why?
|
Workload | 1 | 2016 | 850 | 0.090 |
Why?
|
Aged, 80 and over | 10 | 2013 | 57768 | 0.090 |
Why?
|
Documentation | 1 | 2016 | 869 | 0.090 |
Why?
|
Health Policy | 2 | 2022 | 2661 | 0.090 |
Why?
|
Diet | 3 | 2024 | 7937 | 0.090 |
Why?
|
Educational Measurement | 1 | 2016 | 1209 | 0.080 |
Why?
|
Telemedicine | 1 | 2006 | 2872 | 0.080 |
Why?
|
Self Report | 1 | 2019 | 3558 | 0.080 |
Why?
|
Health Care Costs | 4 | 2021 | 3209 | 0.080 |
Why?
|
Preventive Health Services | 1 | 2012 | 575 | 0.080 |
Why?
|
Thiazides | 1 | 2007 | 18 | 0.080 |
Why?
|
Adrenergic Antagonists | 1 | 2007 | 24 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2013 | 2970 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2023 | 3158 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1797 | 0.070 |
Why?
|
Mammography | 2 | 2016 | 2477 | 0.070 |
Why?
|
Comorbidity | 2 | 2019 | 10387 | 0.070 |
Why?
|
Choice Behavior | 1 | 2012 | 803 | 0.070 |
Why?
|
Health Maintenance Organizations | 3 | 2016 | 642 | 0.070 |
Why?
|
Research Design | 1 | 2022 | 5987 | 0.070 |
Why?
|
Personal Health Services | 1 | 2005 | 25 | 0.070 |
Why?
|
Health Status | 2 | 2015 | 4034 | 0.060 |
Why?
|
Information Services | 1 | 2006 | 244 | 0.060 |
Why?
|
Health Care Reform | 1 | 2014 | 1261 | 0.060 |
Why?
|
Pharmaceutical Services | 1 | 2006 | 140 | 0.060 |
Why?
|
General Surgery | 1 | 2016 | 1636 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2022 | 6485 | 0.060 |
Why?
|
Physician-Patient Relations | 2 | 2010 | 3227 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2010 | 969 | 0.060 |
Why?
|
Attitude to Computers | 1 | 2005 | 202 | 0.060 |
Why?
|
Diuretics | 1 | 2007 | 592 | 0.060 |
Why?
|
Hospitalization | 4 | 2021 | 10262 | 0.060 |
Why?
|
Medical Informatics Applications | 1 | 2005 | 186 | 0.060 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2012 | 941 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9960 | 0.050 |
Why?
|
Longitudinal Studies | 4 | 2023 | 13990 | 0.050 |
Why?
|
Appointments and Schedules | 1 | 2006 | 417 | 0.050 |
Why?
|
Patient Satisfaction | 3 | 2017 | 3395 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3086 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2019 | 63119 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2023 | 77426 | 0.050 |
Why?
|
Sex Distribution | 1 | 2006 | 2297 | 0.050 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2022 | 6037 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12244 | 0.050 |
Why?
|
Chronic Disease | 1 | 2015 | 9147 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 11732 | 0.050 |
Why?
|
Age Distribution | 1 | 2006 | 2903 | 0.040 |
Why?
|
Communication | 3 | 2010 | 3749 | 0.040 |
Why?
|
Odds Ratio | 2 | 2013 | 9849 | 0.040 |
Why?
|
Valproic Acid | 1 | 2022 | 445 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7281 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2024 | 1184 | 0.040 |
Why?
|
Cost of Illness | 1 | 2008 | 1859 | 0.040 |
Why?
|
Policy | 1 | 2022 | 508 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2007 | 6367 | 0.040 |
Why?
|
Antimanic Agents | 1 | 2022 | 522 | 0.040 |
Why?
|
Soil | 1 | 2016 | 106 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5787 | 0.030 |
Why?
|
Medication Reconciliation | 1 | 2017 | 151 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 5396 | 0.030 |
Why?
|
Depression | 1 | 2015 | 7767 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2010 | 19907 | 0.030 |
Why?
|
Psychotherapy | 1 | 2024 | 1645 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2021 | 1660 | 0.030 |
Why?
|
Ambulatory Care | 2 | 2021 | 2708 | 0.030 |
Why?
|
Health Care Surveys | 2 | 2012 | 2453 | 0.030 |
Why?
|
Qualitative Research | 1 | 2021 | 2682 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2016 | 720 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2015 | 25618 | 0.020 |
Why?
|
Economic Recession | 1 | 2012 | 78 | 0.020 |
Why?
|
Risk Factors | 1 | 2018 | 72280 | 0.020 |
Why?
|
Unemployment | 1 | 2012 | 214 | 0.020 |
Why?
|
Consumer Health Information | 1 | 2012 | 211 | 0.020 |
Why?
|
Infant | 2 | 2015 | 35129 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2518 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4037 | 0.020 |
Why?
|
Financing, Government | 1 | 2012 | 468 | 0.020 |
Why?
|
Hospitals, University | 1 | 2010 | 571 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2011 | 397 | 0.020 |
Why?
|
New York City | 1 | 2010 | 710 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2015 | 1583 | 0.020 |
Why?
|
Propensity Score | 1 | 2013 | 1781 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 3913 | 0.020 |
Why?
|
Smoking | 1 | 2022 | 8986 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5319 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5252 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2006 | 513 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2011 | 2374 | 0.020 |
Why?
|
Educational Status | 1 | 2012 | 2539 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2291 | 0.010 |
Why?
|
Health Personnel | 1 | 2016 | 3216 | 0.010 |
Why?
|
Computers | 1 | 2005 | 611 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15538 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9685 | 0.010 |
Why?
|
Hypolipidemic Agents | 1 | 2006 | 604 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15226 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5953 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2010 | 2266 | 0.010 |
Why?
|
Disease Progression | 1 | 2013 | 13280 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2006 | 2047 | 0.010 |
Why?
|
Regression Analysis | 1 | 2006 | 6461 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2010 | 5316 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 21752 | 0.010 |
Why?
|
Databases, Factual | 1 | 2010 | 7730 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2006 | 2875 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 13885 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2016 | 20817 | 0.010 |
Why?
|
Concepts
(250)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_